Title: " Evaluating E-cigarette Substitution in Chronic Smokers with Serious Mental Illness: Update on a Clinical Trial"
Dr. Sarah Pratt has been at Dartmouth since 1999 when she completed a clinical internship, followed by a one-year research and clinical post-doctoral fellowship. Her research interests and expertise primarily involve the development of interventions for people with serious mental illness aimed at enhancing health, symptom self-management, community functioning, quality of life, and fitness, as well as studies to evaluate integrated models of physical and mental health care, and assessment of In SHAPE, a fitness promotion program for people with serious mental illness. She also has conducted smoking cessation research for the past 10 years, serving as Site PI on a randomized controlled trial of Chantix and as Co-PI on a large, statewide study that assessed the use of incentives to encourage smoking cessation among Medicaid recipients with SMI. In the course of this work, she developed an interest in research on electronic cigarettes. One of her two currently funded R01s is evaluating the appeal and impact of electronic cigarettes among chronic smokers with SMI who have been unable to quit smoking.
PLEASE NOTE: A light lunch is provided on a first-come basis.
IF you are planning to attend, please respond to Andrea.M.Gilbert@dartmouth.edu